ARTICLE | Clinical News
Ampligen: Update
October 11, 1999 7:00 AM UTC
Hemispherx Biopharma Inc. (HEB), Philadelphia, Penn. Product: Ampligen Business: Infectious diseases Therapeutic category: Viral replication Target: 2-5A enzyme Description: Nucleic acid antiviral ag...